AGIOS PHARMACEUTICALS, INC. (AGIO)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch AGIO
See up to 3 months of AGIO. The 7-day demo opens the 1M and 3M ranges and puts AGIO on your watchlist.
Start 7-day demoLatest AGIO insider trades
Sarah Gheuens - OfficerOpen-market sale$914K- Sarah Gheuens - OfficerOpen-market sale$151K
About AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. is an SEC registrant, filing under CIK 0001439222, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
AGIO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 30,000 | $914K |
AGIO insider transactions (Form 4)
10657 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sarah Gheuens - Officer | Open-market sale | Common stock | 30,000 | $30.48 footnote F2 | $914K | |
| ||||||
 Jay T. Backstrom - Director | Grant or award | Common stock | 1,447 | $0.00 | - | |
| Jay T. Backstrom - Director | Option exercise | Restricted stock units | 1,447 | $0.00 | - | |
| Sarah Gheuens - Officer | Option exercise | Restricted stock units | 8,375 | $0.00 | - | |
| Sarah Gheuens - Officer | Option exercise | Common stock | 8,375 | $0.00 | - | |
| Sarah Gheuens - Officer | Open-market sale | Common stock | 4,007 | $37.56 | $151K | |
 Rahul D. Ballal - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Rahul D. Ballal - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Rahul D. Ballal - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Rahul D. Ballal - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
 Jeffrey D. Capello - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Jeffrey D. Capello - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Jeffrey D. Capello - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Jeffrey D. Capello - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
 Kaye I. Foster-Cheek - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Kaye I. Foster-Cheek - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Kaye I. Foster-Cheek - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Kaye I. Foster-Cheek - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
| Jacqualyn A. Fouse - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Jacqualyn A. Fouse - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Jacqualyn A. Fouse - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Jacqualyn A. Fouse - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
 Maykin Ho - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Maykin Ho - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Maykin Ho - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
| Maykin Ho - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Adams Catherine Owen - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Adams Catherine Owen - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Adams Catherine Owen - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Adams Catherine Owen - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
| David Scadden - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
| David Scadden - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| David Scadden - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| David Scadden - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Cynthia Smith - Director | Option exercise | Restricted stock units | 2,816 | $0.00 | - | |
| Cynthia Smith - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
| Cynthia Smith - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Cynthia Smith - Director | Option exercise | Common stock | 2,816 | $0.00 | - | |
| Krishnan Viswanadhan - Officer | Option exercise | Performance share units | 3,000 | $0.00 | - | |
| Krishnan Viswanadhan - Officer | Grant or award | Restricted stock units | 3,000 | $0.00 | - | |
 Brian Goff - Officer | Option exercise | Performance share units | 39,000 | $0.00 | - | |
| Brian Goff - Officer | Grant or award | Restricted stock units | 39,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Performance share units | 3,000 | $0.00 | - | |
| James William Burns - Officer | Grant or award | Restricted stock units | 3,000 | $0.00 | - | |
| Sarah Gheuens - Officer | Option exercise | Performance share units | 3,000 | $0.00 | - | |
| Sarah Gheuens - Officer | Grant or award | Restricted stock units | 3,000 | $0.00 | - | |
 Cecilia Jones - Officer | Grant or award | Restricted stock units | 3,000 | $0.00 | - | |
| Cecilia Jones - Officer | Option exercise | Performance share units | 3,000 | $0.00 | - | |
 Tsveta Milanova - Officer | Grant or award | Restricted stock units | 3,000 | $0.00 | - | |
| Tsveta Milanova - Officer | Option exercise | Performance share units | 3,000 | $0.00 | - | |
| Jay T. Backstrom - Director | Grant or award | Restricted stock units | 2,927 | $0.00 | - | |
| Jay T. Backstrom - Director | Grant or award | Stock options (right to buy) | 14,950 | $0.00 | - | |
| Adams Catherine Owen - Director | Option exercise | Common stock | 1,976 | $0.00 | - | |
| Adams Catherine Owen - Director | Option exercise | Restricted stock units | 1,976 | $0.00 | - | |
| Jeffrey D. Capello - Director | Option exercise | Common stock | 1,976 | $0.00 | - | |
| Jeffrey D. Capello - Director | Option exercise | Restricted stock units | 1,976 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Common stock | 8,500 | $0.00 | - | |
| James William Burns - Officer | Open-market sale | Common stock | 3,280 | $34.71 | $114K | |
| James William Burns - Officer | Option exercise | Performance share units | 8,500 | $0.00 | - | |
| Sarah Gheuens - Officer | Option exercise | Common stock | 8,500 | $0.00 | - | |
| Sarah Gheuens - Officer | Open-market sale | Common stock | 2,940 | $34.71 | $102K | |
| Sarah Gheuens - Officer | Option exercise | Performance share units | 8,500 | $0.00 | - | |
| Cecilia Jones - Officer | Option exercise | Common stock | 8,500 | $0.00 | - | |
| Cecilia Jones - Officer | Open-market sale | Common stock | 3,141 | $34.71 | $109K | |
| Cecilia Jones - Officer | Option exercise | Performance share units | 8,500 | $0.00 | - | |
| Tsveta Milanova - Officer | Option exercise | Common stock | 8,500 | $0.00 | - | |
| Tsveta Milanova - Officer | Open-market sale | Common stock | 3,262 | $34.71 | $113K | |
| Tsveta Milanova - Officer | Option exercise | Performance share units | 8,500 | $0.00 | - | |
| Krishnan Viswanadhan - Officer | Option exercise | Common stock | 8,100 | $0.00 | - | |
| Krishnan Viswanadhan - Officer | Open-market sale | Common stock | 2,959 | $34.71 | $103K | |
| Krishnan Viswanadhan - Officer | Option exercise | Performance share units | 8,100 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Common stock | 25,528 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Common stock | 13,500 | $0.00 | - | |
| Brian Goff - Officer | Open-market sale | Common stock | 12,472 | $34.71 | $433K | |
| Brian Goff - Officer | Open-market sale | Common stock | 6,596 | $34.71 | $229K | |
| Brian Goff - Officer | Option exercise | Performance share units | 25,528 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Performance share units | 13,500 | $0.00 | - | |
| Krishnan Viswanadhan - Officer | Option exercise | Common stock | 8,100 | $0.00 | - | |
| Krishnan Viswanadhan - Officer | Open-market sale | Common stock | 2,959 | $27.80 | $82K | |
| Krishnan Viswanadhan - Officer | Option exercise | Restricted stock units | 8,100 | $0.00 | - | |
| Theodore James Washburn Jr. - Officer | Open-market sale | Common stock | 5,272 | $28.88 | $152K | |
| Brian Goff - Officer | Option exercise | Common stock | 8,500 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Common stock | 18,000 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Common stock | 13,000 | $0.00 | - | |
| Brian Goff - Officer | Open-market sale | Common stock | 3,870 | $28.96 | $112K | |
| Brian Goff - Officer | Open-market sale | Common stock | 8,267 | $28.96 | $239K | |
| Brian Goff - Officer | Open-market sale | Common stock | 5,918 | $28.96 | $171K | |
| Brian Goff - Officer | Grant or award | Restricted stock units | 48,000 | $0.00 | - | |
| Brian Goff - Officer | Grant or award | Stock options (right to buy) | 174,000 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Restricted stock units | 8,500 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Restricted stock units | 18,000 | $0.00 | - | |
| Brian Goff - Officer | Option exercise | Restricted stock units | 13,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Common stock | 4,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Common stock | 5,666 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Common stock | 4,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Common stock | 3,920 | $0.00 | - | |
| James William Burns - Officer | Open-market sale | Common stock | 1,187 | $28.96 | $34K | |
| James William Burns - Officer | Open-market sale | Common stock | 1,187 | $28.96 | $34K | |
| James William Burns - Officer | Open-market sale | Common stock | 1,681 | $28.96 | $49K | |
| James William Burns - Officer | Open-market sale | Common stock | 1,163 | $28.96 | $34K | |
| James William Burns - Officer | Grant or award | Restricted stock units | 14,000 | $0.00 | - | |
| James William Burns - Officer | Grant or award | Stock options (right to buy) | 52,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Restricted stock units | 4,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Restricted stock units | 4,000 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Restricted stock units | 5,666 | $0.00 | - | |
| James William Burns - Officer | Option exercise | Restricted stock units | 3,920 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Recent AGIO Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| SARAH GHEUENS | Officer | 30,000 | $914K | View on EDGAR | |
| - | - | - | - |
Stock trades in AGIO disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
AGIO insider trading FAQ
What is the latest insider trade for AGIO?
AGIOS PHARMACEUTICALS, INC. (AGIO) had 1 insider filing in the last 90 days, with the most recent on 2026-08-06. The full record for AGIO runs to 57 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AGIO stock?
No insider purchases of AGIO were filed in the last 90 days.
How many insiders are selling AGIO stock?
1 insider sale of AGIO was filed in the last 90 days, totaling $914K.
Where can I see AGIO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AGIO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Sarah Gheuens view on EDGAR
- - Jay T. Backstrom view on EDGAR
- - Sarah Gheuens view on EDGAR
- - Rahul D. Ballal view on EDGAR
- - Jeffrey D. Capello view on EDGAR
- - Kaye I. Foster-Cheek view on EDGAR
- - Jacqualyn A. Fouse view on EDGAR
- - Maykin Ho view on EDGAR
- - Adams Catherine Owen view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AGIO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AGIO with a 7-day demo
- AGIO on your watchlist
- Every AGIO Form 4 filing on record
- Up to 3 months of AGIO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
